Medical Devices
-
Michael Greiner leaves Avanos over offer under new CEO
Avanos did not offer Greiner a position comparable to the one he held before becoming interim CEO last year.
By Nick Paul Taylor • April 25, 2025 -
Boston Scientific CFO Dan Brennan to retire after nearly 30 years with the company
Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June 30.
By Nick Paul Taylor • April 25, 2025 -
Explore the Trendline➔
Sitthiphong via Getty ImagesTrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
Medtronic seeks FDA nod for insulin pump, furthering Abbott collab
Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by Abbott.
By Elise Reuter • April 24, 2025 -
Device developers advance AI plans despite Trump uncertainty
Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board members think the agency should keep its leading role.
By Elise Reuter • April 24, 2025 -
Edwards shrugs off tariffs, backs 2025 profit forecast
The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity constraints that have dogged its core business.
By Susan Kelly • April 24, 2025 -
Field Medical raises $40M for PFA in ventricular tachycardia
Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart rhythm disorder.
By Susan Kelly • April 23, 2025 -
Intuitive lowers profit margin forecast due to tariff pressure
CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend timelines for robot purchases.
By Susan Kelly • April 23, 2025 -
Trump tariffs
Who are the United States’ top trading partners?
Explore how over 200 countries’ imports, exports and trade balances with the U.S. last year stack up in this sortable chart.
By Edwin Lopez • April 23, 2025 -
FDA issues early alert for BD catheters due to leaks
BD recalled certain intravascular catheters tied to reports of 10 serious injuries after finding an increase in cracks from “material fatigue.”
By Susan Kelly • April 21, 2025 -
Precision Neuroscience receives FDA clearance for brain implant
The electrode array, which can be implanted for 30 days to map brain activity, is a component of Precision Neuroscience’s planned brain-computer interface system.
By Elise Reuter • April 21, 2025 -
Medtronic gets FDA approval to use Simplera Sync glucose sensor with insulin pumps
The updated device allows users to pair the sensor with Medtronic’s insulin pumps, and is expected to grow the company’s diabetes business.
By Elise Reuter • April 21, 2025 -
Dr. Oz sworn in as CMS administrator
During a ceremony at the Oval Office, Mehmet Oz said he would focus on reducing chronic disease, “modernizing” Medicare and Medicaid, and targeting fraud, waste and abuse in government insurance offerings.
By Emily Olsen • April 21, 2025 -
Intuitive, Boston Scientific and Edwards next up in medtech earnings
Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and competitive dynamics in key markets.
By Nick Paul Taylor • April 21, 2025 -
Retrieved from Ceribell on April 17, 2025
Ceribell wins FDA nod for algorithm to detect pediatric seizures
The clearance adds another feature for Ceribell to leverage as it tries to persuade hospitals to switch from conventional EEG systems.
By Nick Paul Taylor • April 21, 2025 -
Illinois, Minnesota join FTC challenge against $627M Surmodics buyout
The Illinois attorney general said the deal represents a “troubling trend of wealthy investors attempting to limit competition and innovation.”
By Nick Paul Taylor • April 18, 2025 -
HHS overhaul
FDA cuts outlined in draft HHS budget
The draft budget would slash FDA’s budget authority, if approved by Congress.
By Elise Reuter • April 18, 2025 -
HHS overhaul
Budget draft outlines Trump’s plan to slash federal health programs
An OMB document proposes to cut the HHS budget by roughly one-third as well as eliminate several divisions and programs.
By Sydney Halleman • April 17, 2025 -
DaVita hit by ransomware attack
The kidney dialysis firm doesn’t have an estimate for how long disruption from the attack will last, though DaVita stressed it’s continuing to provide patient care.
By Emily Olsen • April 17, 2025 -
Abbott expects a ‘few hundred million’ in tariff costs in 2025
CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs.
By Elise Reuter • April 16, 2025 -
Trump tariffs
US launches probe into semiconductor imports
The Section 232 investigation comes ahead of anticipated tariffs on the industry.
By Philip Neuffer • April 15, 2025 -
Trump tariffs
J&J expects tariff charge of $400M this year
CFO Joe Wolk, who revealed the figure Tuesday morning on CNBC, told investors the charge was primarily in the healthcare giant’s medtech business.
By Ricky Zipp • April 15, 2025 -
J&J completes first surgeries with Ottava robot
Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which was performed in the clinical trial.
By Susan Kelly • April 15, 2025 -
Edwards receives CE mark for Sapien M3 mitral valve replacement device
The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s Mitraclip.
By Nick Paul Taylor • April 15, 2025 -
Trump tariffs
Tariffs top of mind for medtech firms this earnings season
GE Healthcare and Medtronic said they are preparing mitigation plans as they assess the potential ramifications of Trump’s tariff policies.
By Susan Kelly • April 14, 2025 -
Late-stage digital health funding rebounds in Q1: Rock Health
The median deal size for late-stage funding rounds was $105 million, nearly double the $55 million check size across 2024.
By Emily Olsen • April 14, 2025